Solstice Advanced Materials Inc. SOLS Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Simulations PlusSLP

$73K-59.2%

Bristow GroupVTOL

$180K+300%

Helen Of TroyHELE

$4.48M-33.3%

Consensus Cloud Solutions, Inc.CCSI

$2.87M-48.5%

BioventusBVS

$3.06M+8.0%

GitLabGTLB

$1.02M-11.7%

Other financials

Income statement

See full

Revenue$991.0M+10.5%

Gross profit$316.0M-1.3%

Net income$85.0M-36.6%

EPS (diluted)$0.53-37.6%

Balance sheet

See full

Cash & equivalents$642.0M-3.9%

Total debt$2.2B—

Total equity$1.5B-54.0%

Total assets$5.7B—

Cash flow

See full

Operating cash flow$199.0M+24.4%

CapEx$75.0M+21.0%

Free cash flow$124.0M+26.5%

Valuation

See full

Market cap$13.13B+83.6%

Enterprise value$14.72B—

P/E69.9×—

P/S3.3×—

Profitability

See full

Gross margin31.3%—

Net margin4.7%—

FCF margin12.6%—

Returns & leverage

See full

Return on equity8%—

Debt / equity1.5×—

Current ratio1.4×—

Where this comes from

Reported directly by Solstice Advanced Materials Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Solstice Advanced Materials Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solstice Advanced Materials Inc. 's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solstice Advanced Materials Inc. 's allowance for doubtful accounts receivable (current)?: Solstice Advanced Materials Inc. (SOLS) reported allowance for doubtful accounts receivable (current) of $5M in Q1 2026.
What does allowance for doubtful accounts receivable (current) mean?: This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.